1859 Welcomes Sanket Agrawal As New CEO

Jun 21, 2023•about 2 years ago

Position

Chief Executive Officer

Company

1859

Sanket Agrawal

San DiegoScience And EngineeringData And AnalyticsHealth Care

Description

1859, an AI-based small molecule drug discovery company advancing next generation medicines, is pleased to announce the appointment of Sanket Agrawal as its Chief Executive Officer , effective April 2023. As an experienced biopharma business leader, Agrawal joins 1859 to drive its next stage of growth and deliver on the company’s potential to rapidly discover superior molecules. The company has demonstrated its discovery engine capabilities through more than 15 partnerships with pharmaceutical, biotech, and academic organizations, yielding novel small molecule compound designs for multiple targets.

Company Information

Company

1859

Location

San Diego, California, United States

About

We are accelerating drug discovery to deliver treatments to patients faster. Our powerful engine integrates combinatorial chemistry, pico-scale activity-based screening, and AI, generating millions of empirical datapoints every week to evolve our models. This enables our biologists and medicinal chemists to discover novel small molecule therapeutics rapidly.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Sanket hidden